Evidence map›Paper›PMID 42289014›Full record

ArticleJournal of cancer research and clinical oncology2026

Loneliness in prostate cancer survivors.

Lukas Lunger, Maximilian Schwoy, Andreas Dinkel, Valentin H Meissner, Stefan Schiele, Matthias Jahnen, Jürgen E Gschwend, Kathleen Herkommer

Abstract readMulticenter Study
In one paragraph

Article in Journal of cancer research and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lukas LungerDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany. lukas.lunger@tum.de.ORCID http://orcid.org/0000-0002-4392-3345
Maximilian SchwoyDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Andreas DinkelDepartment of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Valentin H MeissnerDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Stefan SchieleDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Matthias JahnenDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Jürgen E GschwendDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Kathleen HerkommerDepartment of Urology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLoneliness in cancer survivors is associated with a variety of negative consequences to physical and mental health. Research regarding the impact of loneliness on health-related quality of life and mental health outcomes in prostate cancer (PC) survivors is scarce. The current study aimed to investigate prevalence and determinants of loneliness in long-term PC survivors following radical prostatectomy (RP).

methodsA total of 3127 PC survivors (mean age 79.5 years, SD 6.4) from the multicenter German Familial PC Database returned the study questionnaires during the COVID-19 pandemic, after an average of 17.4 years (SD = 3.8) following RP. Loneliness was assessed using a single item measure. Validated self-reporting questionnaires were used to assess anxiety and depressive symptoms, health related quality of life, and frailty. Descriptive statistics, chi-square tests, and logistic regression analysis were conducted to examine the prevalence, correlates, and determinants of loneliness in PC patients.

resultsOverall, 16.6% of patients reported at least some degree of loneliness. Partnership status, depression, and anxiety were significantly associated with loneliness. Individuals living in a partnership experienced lower levels of loneliness (p < 0.001), while higher levels of depression and anxiety were associated with increased loneliness (p < 0.001). In multivariable logistic regression analysis, having a steady partnership was associated with a significantly lower risk of loneliness (OR 0.18, 95%CI [0.13-0.24]). Symptoms of depression (OR 1.49, 95%CI [1.31-1.71]) or anxiety (OR 1.29, 95%CI [1.13-1.47]) or being frail (OR 3.97, 95%CI [2.99-5.28]) were independently associated with an increased risk of being lonely.

conclusionsNearly one in five PC survivors experienced some to severe loneliness in this study, with notable associations with partnership status, symptoms of depression or anxiety and frailty. The findings emphasize the importance of addressing loneliness as part of comprehensive care for PC survivors.

Indexed as

Cancer SurvivorsLonelinessProstatic NeoplasmsAgedAged, 80 and overAnxietyDepressionGermanyHumansMaleProstatectomyQuality of LifeSurveys and QuestionnairesAnxietyDepressionFrailtyLonelinessProstate cancerRadical prostatectomy

Identifiers

PMID42289014
PMCPMC13269604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.